The Clinical Research Unit at The Neuro — one of the largest neurological trial centres in Canada — is celebrating 40 years at the forefront of the cutting-edge therapies with a symposium that brings together international leaders developing the latest generation of treatments.
This day-long event is designed for scientists, health professionals and stakeholders from academia and industry involved in the development of novel therapeutics for rare diseases and offers a unique opportunity to connect with international researchers.
The symposium is a satellite event of the American Society of Human Genetics Annual Meeting in Montreal, and takes place the day before the start of ASHG proceedings.
EVENT INFORMATION
Date: Monday, October 19, 2026
Sessions: 9am to 4:30pm
Networking cocktail: 4:30pm to 6pm
Location: Le Centre Sheraton
1201 boul. René-Lévesque Ouest
Montréal, Québec, H3B 2L7
Métro: Bonaventure
Fyodor Urnov
University of California, Berkely
We are excited to announce Fyodor Urnov as the keynote speaker for the Future of Advanced Therapeutics in Neurology symposium.
Urnov is a professor of molecular therapeutics at the University of California, Berkely and director for therapeutic R&D of its Innovative Genomics Institute (IGI).
A key focus of Urnov’s work has been expanding access to CRISPR therapies for genetic disease. He directs the Danaher-IGI Beacon for CRISPR Cures – an academia-industry partnership developing and advancing to the clinic CRISPR-based platform approaches to treat severe Mendelian diseases of the immune system. He also directs the newly established CZI-IGI Center for Pediatric CRISPR Cures that aims to expand the “CRISPR on-demand” approach exemplified in that effort to multiple additional pediatric patients with severe genetic diseases.